Prosecution Insights
Last updated: October 26, 2026

Sharon X Wen, USPTO Patent Examiner

Listed by the USPTO as WEN, SHARON X

Tech Center 1700 • Art Units: 1641 1642 1644 1684 1759

This examiner grants 57% of resolved cases

Analysis

WEN, SHARON X is a USPTO patent examiner in Tech Center 1700 and Art Unit 1641. The record includes 639 resolved cases and a 56.8% allowance rate. The median time to allowance is 1369 days. Interviews show a 32.6% lift, indicating that applicant interaction can improve results over a moderate baseline. Given the long median timeline, applicants may benefit from addressing the main technical issue through an interview before pursuing multiple amendment cycles.

The listed companies are Amgen Inc., The Brigham and Women's Hospital Inc., and Genentech Inc. The leading firms are Knobbe, Martens, Olson & Bear, LLP, ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM LLP, and DUANE MORRIS LLP - NY. The company mix is concentrated in biotechnology and medical research. Practitioners should prepare scientifically precise explanations and preserve support for each proposed claim limitation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

56.8%
Allow Rate
-8.2% vs TC avg
671
Total Applications
+32.6%
Interview Lift
1369
Avg Prosecution Days
Based on 639 resolved cases, 2023–2026

Rejection Statute Breakdown

2.9%
§101 Eligibility
19.9%
§102 Novelty
20.7%
§103 Obviousness
32.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17780407 COMPOSITIONS AND METHODS FOR EPITOPE SCANNING Non-Final OA The Brigham and Women's Hospital, Inc.
17984611 DPP3 BINDER DIRECTED TO AND BINDING TO SPECIFIC DPP3-EPITOPES AND ITS USE IN THE PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS THAT ARE ASSOCIATED WITH OXIDATIVE STRESS Final Rejection 4TEEN4 Pharmaceuticals GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sharon X Wen's allowance rate?

56.8% of resolved applications examined by Sharon X Wen were allowed (639 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.

Does an interview help with examiner Sharon X Wen?

This examiner's interview lift is +32.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sharon X Wen take to allow a patent?

Applications allowed by Sharon X Wen took 1,369 days on average from filing to allowance.

Which art unit does examiner Sharon X Wen work in?

Sharon X Wen examines applications in Art Unit 1641 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month